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Abstract: 
Malaria, caused by protozoan parasites of the genus Plasmodium, affects up to 500 million individuals and kills over 1 
million people every year. The increasing resistance of the malaria parasites has enforced strategies for finding new drug 
targets.  In recent years, enzymes associated with the polyamine metabolism have attracted attention as drug targets.   
Cytosolic  Plasmodium falciparum spermidine synthase (PfPAPT) is a potential target for antimalarial chemotherapy. 
Contrasting with the other enzymes involved in the parasite polyamine amine biosynthesis, little information is available 
about this enzyme, and its crystallographic structure is unknown yet. In this paper I propose a theoretical low-resolution 3D 
model for PfPAPT based on crystal structure of the Arabidopsis thaliana, by multiple alignment followed by intensive 
optimization; validation and dynamic simulations in water. Comparison between the active sites of PfPAPT and human 
PAPT revealed key differences that could be useful for the design of new selective inhibitors of Plasmodium PAPT. 
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Background: 
Unicellular parasites such as Plasmodium falciparum 
(malaria), Leishmania major (leishmaniosis), Trypanosoma 
brucei (sleeping sickness), Trypanosoma cruzi (Chagas 
disease) and Toxoplasma gonadii (toxoplasmosis) are 
responsible for the world’s most widespread diseases. 
Malaria remains a major and growing threat to the public 
health and economic development of countries in the 
tropical and subtropical regions of the world. [1] 
Approximately 40% of the world’s population live in areas 
where malaria is endemic. There are estimated 300-500 
million cases and up to 2.7 million deaths from malaria 
each year, most of them from Africa. In addition, travelers 
and soldiers are at significant risk for exposure to malaria. 
Human malaria is caused by infection with intracellular 
parasites of the genus Plasmodium that is transmitted by 
Anopheles gambiae mosquitoes. Plasmodium requires two 
hosts: the Anopheles mosquito for the sexual reproductive 
stages and humans for the asexual reproductive stages. The 
infectious sporozoites are injected by the mosquito into 
blood vessels in the skin. They invade hepatocytes and 
begin the exoerythrocytic cycle, which generates thousands 
of merozoites (schizogony). After rupture of the 
hepatocyte, the merozoites enter the bloodstream and begin 
the erythrocytic cycle by invading red blood cells, forming 
trophozoites. Replication in the erythrocyte (schizogony) 
culminates in rupture and release of a small number of 
merozoites, which initiate another cycle of replication by 
infecting other erythrocytes. Among four species of 
Plasmodium that infect humans, P.falciparum is the most 
lethal. Drug resistance is increasing even to newer anti-
malarial drugs such as mefloquine. [2] This has led to an 
urgent need for new anti-malarial drugs both for 
chemotherapy and prophylaxis. 
 
The current approach in the anti-parasitic drug discovery 
involves the identification of novel targets from the 
databases on the parasite genome and metabolic pathways. 
In recent years, enzymes associated with the polyamine 
metabolism have attracted attention as drug targets.  The 
ubiquitously distributed polyamines spermidine and 
spermine are aliphatic polycations that are involved in 
numerous cellular functions. Changes of intracellular 
polyamine concentrations were shown to correlate with 
growth and differentiation processes of pro- and 
eukaryotes. In polyamine synthesis, spermidine synthase 
catalyses the transfer of an aminopropyl moiety of 
decarboxylated S-adenosylmethionine (dcAdoMet) to 
putrescine, resulting in the formation of spermidine and 5’ 
methylthioadenosine (MTA). [3] During the asexual cycle 
of Plasmodium falciparum within the host erythrocyte, the 
parasite induces a stage-dependent elevation in the levels of 
polyamines by increased metabolism and uptake of extra-
cellular pools. The enzymes associated with biosynthetic 
pathway of polyamines exhibit features that differ 
significantly between the parasites and the human host. 
Therefore it is conceivable that exploitation of such 
differences can lead to the design of new inhibitors that will 
selectively kill the parasites while exerting minimal or at Bioinformation by Biomedical Informatics Publishing Group                   open access 
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least tolerable, effects on the parasite-infected patient. [4] 
The gene encoding spermidine synthase was cloned 
recently from P.falciparum. Northern and Western blot 
analyses revealed a stage specific expression during the 
erythrocytic schizogony with the maximal amount of 
transcript and protein in mature trophozoites. The 
spermidine synthase polypeptide of 321 amino acids has a 
molecular mass of 36.6kDa and contains an N-terminal 
extension of unknown function that, similarly, is also found 
in certain plants but not in animal or bacterial orthologues. 
In transient expression analysis experiments the enzyme 
catalyses the transfer of an aminopropyl group from 
decarboxylated S-adenosylmethionine [dcAdoMet] onto 
putrescine. In contrast to mammalian spermidine synthases, 
spermidine can replace to some extent putrescine as the 
aminopropyl acceptor. Hence, P. falciparum spermidine 
synthase has the capacity to catalyse the formation of 
spermine. [5] The functional differences observed could be 
due to the structural differences and might be further 
exploited for the development of the antimalarial drugs. 
Therefore it is our interest to study the structural features of 
spermidine synthase from P.falciparum.  The structure of 
spermidine synthase from P.falciparum is unknown. In the 
absence of the experimentally determined structure, 
molecular modeling is usually the method of choice, when 
there is clear relationship of homology between the 
sequence of target protein and at least one known structure. 
 
Methodology: 
The single letter amino acid sequence of P.falciparum 
PAPT (Q8II73) was retrieved from SWISS PROT [6] and 
taken as target sequence. The modeling of 3D structure of 
PfPAPT followed a stepwise procedure, starting with a 
template structure search from PDB (protein databank) [7], 
related to the target sequence using BLASTP. [8] From a 
number of hits, a potential template structure (PDB-ID: 
IXJ5), representing the structure of spermidine synthase 
form Arabidopsis thaliana was taken as template for model 
building. The structure of the multi-substrate adduct 
inhibitor AdoDATO was taken from the crystal structure of 
Thermotoga Maritima (PDB-ID: 1JQ3). 
 
Model Building, evaluation and active site analysis 
The template and target sequences were aligned using the 
MALIGN script. After careful examination for the potential 
alignment errors, the automated comparative protein 
modelling program MODELLER7v7 was used to build the 
model. [9] In the first step of model building, distance and 
dihedral angle restraints on the target sequence were 
derived from its alignment with the template 3D-structure.  
The spatial restraints and the energy minimization steps 
were performed with the CHARMM22 force field for 
proper stereochemistry of proteins. Then, optimization of 
the model was carried out by the molecular dynamics 
simulated annealing method. The modeled structure with 
minimum objective function was taken and evaluated by 
the PROCHECK. [10] The overall stereochemical quality 
of the protein was assessed by Ramachandran plot analysis. 
[11] The modeled 3D structure of PfPAPT was used for 
docking with PAPT inhibitor to find the active pocket of 
ligand binding using the Hex4.2 [12] macromolecular 
docking program with default parameters of the docking 
module. 
 
 
Figure 1: (A) Predicted model of Plasmodium falciparum spermidine synthase [PDB ID:  2ce5] in sterio view. (B & C) 
Electrostatic potential differences mapped on to the active site resides with-in the 5 A
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Results and discussion: 
The result of the protein-protein BLAST search for a 
suitable template structure related to the target sequence 
(PfPAPT) showed Arabidopsis thaliana spermidine 
synthase with highest sequence similarity (47%), as the 
most suitable template for modeling. In total twenty five 
models were generated by MODELLER 7V7, and the 
model with the lowest objective function (967.8491) was 
selected as the best and subjected to “internal” evaluation 
of self-consistency checks such as stereochemical check to 
find the deviations from normal bond lengths, dihedrals and 
non-bonded atom-atom distances. The PROCHECK 
Ramachandran plot analysis shows 91.3% of the residues 
are in the core region, 6.4% in the allowed and 2.3% in the 
generously allowed regions. No residues were found in the 
disallowed region of the Ramachandran plot showing that 
no residues have a disallowed conformation. The Goodness 
factors (G-factors), from the PROCHECK results summary 
show the quality of covalent and overall bond/angle 
distances. The observed G-factors for the present model 
were -0.10 for dihedrals, -0.17 for covalent and overall 
0.01. The comparable Ramachandran plot characteristic 
and the goodness factors confirm the quality of the 
modelled structure. The evaluated final model has been 
deposited in PDB and is now publicly accessible [PDB ID: 
2ce5]. The protein structure predicted is displayed in figure 
1A. The overall topology of the modelled spermidine 
synthase from Plasmodium falciparum, like other members 
of the enzyme family, consists the typical two domains. 
The larger C-terminal catalytic core domain consists of 
seven–stranded  β-sheets flanked by nine α-helices. A 
PAPT family signature V-[LA]-[LIV] [2]-G-G-G-X[2]-
[LIV]-X-E (where X is any amino acid)  which is 
previously defined in [PROSITE entry PS01330] is 
identified in the core catalytic domain at C-terminus 
between  β8-α6.  The RMSD (Root Mean Square 
Deviation) between predicted model and template is 0.4 
angstrom.  
 
The structure of T.maritima and human PAPT were 
determined in complex with inhibitor AdoDATO and with 
AdoMet, respectively. The structures demonstrate a high 
level of conservation of the overall topology. Thus the 
structures of T.maritima and human PAPT could be 
superimposed on the P.falciparum PAPT with rmsd for the 
C-α atoms of around 1 A
0. The largest differences between 
the P.falciparum and T.maritima were found in the regions 
of helix α3, α4, and α6 (residues 142-151, 168-177 and 
230-242, respectively. A superimposition of the structures 
of human and T.maritima PAPT shows that the differences 
are maintained from the α3 and α6, while α4 superimposes 
well on the corresponding helix from the T.maritima 
enzyme. Taking into account that α4 builds up part of the 
substrate binding cleft, the differences between human and 
P.falciparum enzymes may be of interest for future design 
of plasmodium specific inhibitors. 
 
Search for the ligand binding pocket using multisubstrate 
adduct inhibitor AdoDATO, resulted in the identification of 
active site. Active site residues were then searched for the 
differences and the electrostatic potentials were mapped on 
to the surface. Amino acid residues with in the 5 A
o 
distance surrounding the Active site display qualitative 
electrostatic potential differences (Fig1 B and C). The 
structure of T.maritima PAPT in complex with AdoDATO 
shows that the putricine-binding site is a hydrophobic 
cavity, which includes two negatively charged sites 
responsible for anchoring the amino acid groups of the 
molecule. In particular, Asp170 (T.maritima numbering) 
has been proposed to be responsible for deprotonating the 
attacking amino group of putricine, where as Tyr76 and 
Ser171 are thought to be involved in binding and proper 
orientation of the diamine. The corresponding residues in 
the P.falciparum are Tyr90, Asp184 and Ser185. In total 20 
amino acid residues are involved in interaction with the 
inhibitor of these 16 are conserved, where as four have 
been exchanged in P.falciparum. These differences 
observed in the active site architecture could be used to 
design specific inhibitors. 
 
Utility: 
Despite the progress made in anti-malarial research, control 
of malaria has been severely compromised by the 
development of malarial parasites resistant to nearly all 
anti-malarial drugs used for prophylaxis and treatment. In 
order to provide a new target for the development of anti-
malarial drug discovery I have chosen plasmodium 
polyamine biosynthetic pathway enzyme spermidine 
synthase. A molecular model of the spermidine synthase 
from Plasmodium falciparum is documented in this study. 
The model is believed to provide valuable insights towards 
the design of an inhibitor specific to the spermidine 
synthase of Plasmodium falciparum for the treatment of 
malaria, using the provided active site location and 
conformations. 
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